Functional assay for assessment of agonistic or antagonistic activity of angiotensin AT2 receptor ligands reveals that EMA401 and PD123319 have agonistic properties
Open Access
- 7 September 2023
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 216, 115793
Abstract
No abstract availableKeywords
Funding Information
- Danmarks Frie Forskningsfond (4004-00485B)
- Novo Nordisk Fonden (6239)
This publication has 24 references indexed in Scilit:
- Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profilesCellular Signalling, 2011
- A Single β-Amino Acid Substitution to Angiotensin II Confers AT2Receptor Selectivity and Vascular FunctionHypertension, 2011
- Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κBHypertension, 2010
- The Angiotensin II Type 2 Receptor Causes Constitutive Growth of Cardiomyocytes and Does Not Antagonize Angiotensin II Type 1 Receptor–Mediated HypertrophyHypertension, 2005
- The AT2 receptor—A matter of love and hatePeptides, 2005
- Angiotensin-(1–7) Acts as a Vasodepressor Agent Via Angiotensin II Type 2 Receptors in Conscious RatsHypertension, 2005
- Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT2 Receptor AgonistJournal of Medicinal Chemistry, 2004
- Differential role of angiotensin II receptor subtypes on endothelial superoxide formationBritish Journal of Pharmacology, 2000
- Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cellsMolecular and Cellular Endocrinology, 1995
- Angiotensin II AT2 receptors do not interact with guanine nucleotide binding proteinsEuropean Journal of Pharmacology: Molecular Pharmacology, 1991